

Josh Hardy, the little boy fighting for his life as an adenovirus infection ravages his body, has just been enrolled

Chimerix, a drug company that manufactures the still-developmental drug Brincidofovir, is denying the potentially lifesaving drug to 7-year-old Josh Hardy.